SPRO
Spero Therapeutics Inc

2,758
Mkt Cap
$144.79M
Volume
150,689.00
52W High
$3.22
52W Low
$0.5052
PE Ratio
-3.21
SPRO Fundamentals
Price
$2.55
Prev Close
$2.57
Open
$2.57
50D MA
$2.37
Beta
0.86
Avg. Volume
275,037.32
EPS (Annual)
-$1.27
P/B
5.42
Rev/Employee
$856,125.00
Loading...
Loading...
News
all
press releases
Spero Therapeutics (NASDAQ:SPRO) Raised to "Buy" at Wall Street Zen
Wall Street Zen upgraded shares of Spero Therapeutics from a "hold" rating to a "buy" rating in a report on Sunday...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Downgraded by Wall Street Zen to Hold
Wall Street Zen downgraded shares of Spero Therapeutics from a "buy" rating to a "hold" rating in a report on Saturday...
MarketBeat·8d ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Stock Crosses Below 200-Day Moving Average - Here's What Happened
Spero Therapeutics (NASDAQ:SPRO) Stock Price Crosses Below 200 Day Moving Average - Here's What Happened...
MarketBeat·11d ago
News Placeholder
Spero Therapeutics, Inc. (NASDAQ:SPRO) Sees Large Growth in Short Interest
Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totaling 1,056,013...
MarketBeat·11d ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Stock Price Crosses Below 200 Day Moving Average - Time to Sell?
Spero Therapeutics (NASDAQ:SPRO) Shares Cross Below 200 Day Moving Average - Time to Sell...
MarketBeat·19d ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Upgraded to "Buy" at Wall Street Zen
Wall Street Zen raised Spero Therapeutics from a "hold" rating to a "buy" rating in a research report on Sunday...
MarketBeat·28d ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded Spero Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·1mo ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Upgraded to "Buy" at Wall Street Zen
Wall Street Zen raised Spero Therapeutics from a "hold" rating to a "buy" rating in a research note on Friday...
MarketBeat·1mo ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Shares Pass Above 200 Day Moving Average on Insider Selling
Spero Therapeutics (NASDAQ:SPRO) Shares Cross Above Two Hundred Day Moving Average After Insider Selling...
MarketBeat·2mo ago
News Placeholder
Spero Therapeutics (NASDAQ:SPRO) Issues Earnings Results, Beats Estimates By $0.12 EPS
Spero Therapeutics (NASDAQ:SPRO - Get Free Report) announced its earnings results on Thursday. The company reported ($0.13) EPS for the quarter, topping analysts' consensus estimates of ($0.25) by...
MarketBeat·2mo ago
<
1
2
...
>

Latest SPRO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.